Post-IPO Equity - Cogent Biosciences
Investment Firm
Overview
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Announced Date
Feb 13, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Participant Investors
8
Round Details and Background
Cogent Biosciences raised $225000000 on 2024-02-13 in Post-IPO Equity
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 13, 2024 |  Post-IPO Equity - Cogent Biosciences | 9 | - | 225.0M |
| Mar 15, 2017 | Debt Financing - Cogent Biosciences | 1 | - | 15.0M |
| Jun 11, 2015 | Series B - Cogent Biosciences | 12 | - | 65.0M |
| Oct 21, 2014 | Series A - Cogent Biosciences | 4 | - | 12.3M |
Recent Activity
There is no recent news or activity for this profile.